Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchodilatation of GSK961081 Alone and With Short-Acting Bronchodilators in COPD
NCT00674817Phase 2Completed
- Sponsor
- Theravance Biopharma, Inc.
- Start
- Apr 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of batefenterol in chronic obstructive pulmonary disease (COPD), sponsored by Theravance Biopharma, Inc.. Started Apr 2008; status: completed.
02
Drugs
batefenterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00674817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00674817.